Anne Dørum, Ketil Heimdal, Eivind Hovig, Mats Inganäs, Pål Møller

Slides:

Advertisements

Similar presentations

Novel PMS2 Pseudogenes Can Conceal Recessive Mutations Causing a Distinctive Childhood Cancer Syndrome Michel De Vos, Bruce E. Hayward, Susan Picton, Eamonn.

Advertisements

Previous Estimates of Mitochondrial DNA Mutation Level Variance Did Not Account for Sampling Error: Comparing the mtDNA Genetic Bottleneck in Mice and.

Connexin Mutations in Skin Disease and Hearing Loss David P. Kelsell, Wei-Li Di, Mark J. Houseman The American Journal of Human Genetics Volume 68, Issue.

Functional Analysis of the Neurofibromatosis Type 2 Protein by Means of Disease- Causing Point Mutations Renee P. Stokowski, David R. Cox The American.

Gene Preference in Maple Syrup Urine Disease Mary M. Nellis, Dean J. Danner The American Journal of Human Genetics Volume 68, Issue 1, Pages (January.

De Novo BRCA1 Mutation in a Patient with Breast Cancer and an Inherited BRCA2 Mutation Andrea Tesoriero, Chris Andersen, Melissa Southey, Gino Somers,

Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part I: Methods and Power Analysis Douglas F. Levinson, Matthew D. Levinson, Ricardo Segurado,

Fragile X and X-Linked Intellectual Disability: Four Decades of Discovery Herbert A. Lubs, Roger E. Stevenson, Charles E. Schwartz The American Journal.

Genetic testing for high-risk colon cancer patients1 William M. Grady Gastroenterology Volume 124, Issue 6, Pages (May 2003) DOI: /S (03)

Telomerase Activity and Expression of Telomerase RNA Component and Telomerase Catalytic Subunit Gene in Cervical Cancer Kenji Nakano, Elizabeth Watney,

Celiac Disease Genetics: Current Concepts and Practical Applications Ludvig M. Sollid, Benedicte A. Lie Clinical Gastroenterology and Hepatology Volume.

The Duty to Recontact: Attitudes of Genetics Service Providers Jennifer L. Fitzpatrick, Cecil Hahn, Teresa Costa, Marlene J. Huggins The American Journal.

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.

Peopling of Sahul: mtDNA Variation in Aboriginal Australian and Papua New Guinean Populations Alan J. Redd, Mark Stoneking The American Journal of Human.

Evidence for Autosomal Dominant Inheritance of Prostate Cancer

Diagnostic Testing for Rett Syndrome by DHPLC and Direct Sequencing Analysis of the MECP2 Gene: Identification of Several Novel Mutations and Polymorphisms

The Role of MMAC1 Mutations in Early-Onset Breast Cancer: Causative in Association with Cowden Syndrome and Excluded in BRCA1-Negative Cases Hui C. Tsou,

Identification and Characterization of Optimal Gene Expression Markers for Detection of Breast Cancer Metastasis John Backus, Todd Laughlin, Yixin Wang,

Schizophrenia and Affective Disorders—Cosegregation with a Translocation at Chromosome 1q42 That Directly Disrupts Brain-Expressed Genes: Clinical and.

Hereditary Nonpolyposis Colorectal Cancer in 95 Families: Differences and Similarities between Mutation-Positive and Mutation-Negative Kindreds Rodney.

The APC I1307K Allele and BRCA-Associated Ovarian Cancer Risk

An Unknown Genetic Defect Increases Venous Thrombosis Risk, through Interaction with Protein C Deficiency Sandra J. Hasstedt, Edwin G. Bovill, Peter.

High Prevalence of Pathogenic Mutations in Patients with Early-Onset Dementia Detected by Sequence Analyses of Four Different Genes Ulrich Finckh, Tomas.

Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families Paul D.P. Pharoah,

Association of Family History of Specific Cancers With a Younger Age of Onset of Pancreatic Adenocarcinoma Robert R. McWilliams, William R. Bamlet, Kari.

CHEK2*1100delC and Susceptibility to Breast Cancer: A Collaborative Analysis Involving 10,860 Breast Cancer Cases and 9,065 Controls from 10 Studies

Quiz page American Journal of Kidney Diseases

Patrick R. Murray The Journal of Molecular Diagnostics

Next-Generation Sequencing of the BRCA1 and BRCA2 Genes for the Genetic Diagnostics of Hereditary Breast and/or Ovarian Cancer Daniel Trujillano, Maximilian.

Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined.

The Origin of Abnormalities in Recurrent Aneuploidy/Polyploidy

Shih-Jen Hwang, Guillermina Lozano, Christopher I. Amos, Louise C

Patricia N. Tonin, Anne-Marie Mes-Masson, P

Genetics, Individuality, and Medicine in the 21st Century*

Pathogenicity Evaluation of BRCA1 and BRCA2 Unclassified Variants Identified in Portuguese Breast/Ovarian Cancer Families Catarina Santos, Ana Peixoto,

The American Journal of Human Genetics

Hilmi Ozcelik, Xuejiang Shi, Martin C

XMCPDT Does Have Correct Type I Error Rates

A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer Pia Vahteristo, Jirina Bartkova, Hannaleena Eerola, Kirsi Syrjäkoski,

Predictors of the Risk of Mortality in Neurofibromatosis 2

The Molecular Pathology of Primary Immunodeficiencies

GeneTests: Integrating Genetic Services into Patient Care*

A Second Gene for Autosomal Dominant Möbius Syndrome Is Localized to Chromosome 10q, in a Dutch Family H.T.F.M. Verzijl, B. van den Helm, B. Veldman,

Use of a Quantitative Trait to Map a Locus Associated with Severity of Positive Symptoms in Familial Schizophrenia to Chromosome 6p L.M. Brzustowicz,

Inherited Mutations in PTEN That Are Associated with Breast Cancer, Cowden Disease, and Juvenile Polyposis Eric D. Lynch, Elizabeth A. Ostermeyer, Ming.

Laurent Gouya Journal of Investigative Dermatology

Correction Journal of the American College of Surgeons

Francois le Pelletier, Anne Janin Journal of Investigative Dermatology

E. Warwick Daw, Simon C. Heath, Ellen M. Wijsman

Erratum The American Journal of Human Genetics

Hereditary Nonpolyposis Colorectal Cancer in 95 Families: Differences and Similarities between Mutation-Positive and Mutation-Negative Kindreds Rodney.

Evidence That the Penetrance of Mutations at the RP11 Locus Causing Dominant Retinitis Pigmentosa Is Influenced by a Gene Linked to the Homologous RP11.

Meiotic Microdeletion Breakpoints in the BRCA1 Gene Are Significantly Associated with Symmetric DNA-Sequence Elements Beatrice Schmucker, Michael Krawczak

Greg L. Loeben, Theresa M. Marteau, Benjamin S. Wilfond

Alexander Liede, Imtiaz A

Victor Almon McKusick, MD, 1921–2008, In Memoriam

Lynda Anne Szczech, Ira L. Lazar Kidney International

by Jennifer Couzin-Frankel

Linkage Analyses at the Chromosome 1 Loci 1q24-25 (HPC1), 1q42

Frequency and Carrier Risk Associated with Common BRCA1 and BRCA2 Mutations in Ashkenazi Jewish Breast Cancer Patients Flora H. Fodor, Ainsley Weston,

BRCA1 and BRCA2 Testing: Weighing the Demand against the Benefits

Giovanni Parmigiani, Donald A. Berry, Omar Aguilar

Heritability of Cellular Radiosensitivity: A Marker of Low-Penetrance Predisposition Genes in Breast Cancer? S.A. Roberts, A.R. Spreadborough, B. Bulman,

Footnotes1 Journal of Allergy and Clinical Immunology

Detection and Integration of Genotyping Errors in Statistical Genetics

Evidence for Autosomal Dominant Inheritance of Prostate Cancer

Alice S. Whittemore, Jerry Halpern

This Month in AJKD American Journal of Kidney Diseases

Mark Gibbs, Janet L. Stanford, Gail P

A Review of First-Line Treatment for Small-cell Lung Cancer

Presentation transcript:

Penetrances of BRCA1 1675delA and 1135insA with Respect to Breast Cancer and Ovarian Cancer Anne Dørum, Ketil Heimdal, Eivind Hovig, Mats Inganäs, Pål Møller The American Journal of Human Genetics Volume 65, Issue 3, Pages 671-679 (September 1999) DOI: 10.1086/302530 Copyright © 1999 The American Society of Human Genetics Terms and Conditions

Figure 1 Age-related penetrances of BRCA1 1675delA (thicker line) and 1135insA (thinner line) in mutation carriers (demonstrated, affected, or obligate). Index cases are not included. a, Breast and/or ovarian cancer (whichever came first) scored as event. b, Ovarian cancer scored as event (breast cancer considered as unaffected). c, Breast cancer scored as event (ovarian cancer considered as unaffected). The American Journal of Human Genetics 1999 65, 671-679DOI: (10.1086/302530) Copyright © 1999 The American Society of Human Genetics Terms and Conditions

Figure 2 Age-related penetrances of BRCA1 1675delA and 1135insA in mutation carriers (demonstrated, affected, or obligate). Consecutive ovarian-cancer series (thicker line) and family cancer-clinic series (thinner line). Index cases are not included. a, Breast and/or ovarian cancer (whichever came first) scored as event. b, Ovarian cancer scored as event (breast cancer considered as unaffected). c, Breast cancer scored as event (ovarian cancer considered as unaffected). The American Journal of Human Genetics 1999 65, 671-679DOI: (10.1086/302530) Copyright © 1999 The American Society of Human Genetics Terms and Conditions

Figure 3 Age-related penetrance in the combined series, including demonstrated mutation carriers and obligate carriers only, with index cases excluded. The American Journal of Human Genetics 1999 65, 671-679DOI: (10.1086/302530) Copyright © 1999 The American Society of Human Genetics Terms and Conditions

Figure 4 Age-related penetrances of BRCA1 1675delA and 1135insA in the consecutive ovarian-cancer series. Only mutation carriers (demonstrated, affected, or obligate) are included; index cases are excluded. a, Ovarian cancer scored as event (patients with breast cancer censored at age at diagnosis). b, Breast cancer scored as event (patients with ovarian cancer censored at age at diagnosis). The American Journal of Human Genetics 1999 65, 671-679DOI: (10.1086/302530) Copyright © 1999 The American Society of Human Genetics Terms and Conditions